Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

23,747 total articles

ABM Reports Fiscal Third Quarter 2026 Results

ABM Reports Fiscal Third Quarter 2026 Results

ABM Industries Incorporated announced strong fiscal third quarter 2026 results with record quarterly revenue of $2.3 billion, a 4.2% increase year-over-year, driven by organic growth and acquisitions, notably in Manufacturing & Distribution and Aviation sectors. The company achieved a 19% increase in net income and adjusted net income, improved adj…

Pharvaris Announces Positive Topline Data from CHAPTER-3 Pivotal Study of Deucrictibant XR for Prophylaxis of HAE Attacks

Pharvaris Announces Positive Topline Data from CHAPTER-3 Pivotal Study of Deucrictibant XR for Prophylaxis of HAE Attacks

Pharvaris announced positive topline results from its CHAPTER-3 pivotal Phase 3 trial demonstrating that deucrictibant extended-release (XR) tablet significantly reduces hereditary angioedema (HAE) attacks by 83% compared to placebo. The treatment was well tolerated, met all primary and secondary efficacy endpoints, and provides early and sustained…

Bullish releases August 2026 monthly metrics

Bullish releases August 2026 monthly metrics

Bullish, a NYSE-listed global digital asset platform, published its unaudited monthly trading metrics for August 2026 including trading volumes, average trading spreads, and volatility data for Bitcoin and Ethereum. The company also reiterated its comprehensive digital asset infrastructure services and provided context on metrics definitions and da…

Bluejay Diagnostics and Lovell Government Services Announce Partnership to Expand Access to U.S. Federal Healthcare Markets

Bluejay Diagnostics and Lovell Government Services Announce Partnership to Expand Access to U.S. Federal Healthcare Markets

Bluejay Diagnostics announced a strategic partnership with Lovell Government Services to establish a federal market access and procurement infrastructure, facilitating the commercial introduction of Bluejay's Symphony near-patient diagnostic platform into large U.S. federal healthcare systems such as the VA, DoD, MHS, and IHS following FDA clearanc…

Nova Minerals’ Marches towards Antimony Production with Arrival of Processing & Refining Equipment in Alaska

Nova Minerals’ Marches towards Antimony Production with Arrival of Processing & Refining Equipment in Alaska

Nova Minerals Corp has received approximately 500 tons of equipment at Port MacKenzie, Alaska, enabling construction of a planned antimony processing and refining facility. This milestone supports the company's goal to establish a secure, fully integrated domestic antimony supply chain, funded by a $43.4 million US Department of War award. Producti…

FTC Solar to Participate in Upcoming Investor Events

FTC Solar to Participate in Upcoming Investor Events

FTC Solar, Inc., a leading provider of solar tracker systems and related services, announced that its management team will attend upcoming investor events including the H.C. Wainwright Global Investment Conference and the TD Cowen Energy Conference. These meetings aim to foster investor relations and provide updates on the company's performance and…

Belite Bio Announces Submission of New Drug Application to the Ministry of Health, Labour, and Welfare in Japan under the Sakigake Designation System for Tinlarebant for the Treatment of Stargardt Disease Type 1

Belite Bio Announces Submission of New Drug Application to the Ministry of Health, Labour, and Welfare in Japan under the Sakigake Designation System for Tinlarebant for the Treatment of Stargardt Disease Type 1

Belite Bio submitted a New Drug Application for tinlarebant to Japan's Ministry of Health under the expedited Sakigake designation for Stargardt disease type 1, a rare inherited retinal disorder. The drug is also under Priority Review by the U.S. FDA with a target action date in early 2027. If approved, tinlarebant would be the first therapy availa…

Roivant Announces Positive Results from PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) and Unveils Ongoing Phase 3 PHrontier Study

Roivant Announces Positive Results from PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) and Unveils Ongoing Phase 3 PHrontier Study

Roivant Sciences announced highly positive Phase 2 trial results for mosliciguat, showing the largest-ever reduction in pulmonary vascular resistance in a randomized controlled pulmonary hypertension trial. Mosliciguat demonstrated significant improvements in six-minute walk distance and cardiac biomarker levels, alongside a favorable safety profil…

MediciNova to Participate in Two Investor Conferences in September

MediciNova to Participate in Two Investor Conferences in September

MediciNova, a clinical-stage biopharmaceutical company listed on NASDAQ (MNOV), announced participation in the H.C. Wainwright and ROTH Capital healthcare conferences in September. Management will discuss progress on their late-stage pipeline, including upcoming topline readouts from Phase 2 and Phase 3 studies involving MN-001 and MN-166 compounds…

Smackover Lithium Announces Positive Preliminary Economic Assessment for the Franklin Project, Its First Lithium Project in East Texas

Smackover Lithium Announces Positive Preliminary Economic Assessment for the Franklin Project, Its First Lithium Project in East Texas

Smackover Lithium, a partnership between Standard Lithium Ltd. (NYSE American: SLI) and Equinor, released a positive Preliminary Economic Assessment (PEA) for the Franklin lithium brine project in East Texas. The PEA highlights impressive economics with an after-tax NPV8 of $5.0 billion, IRR of 24%, and annual production capacity up to 70,000 tonne…

Scripps Howard Fund marks 10 years of ‘If You Give a Child a Book …’ campaign with two-day donation match

Scripps Howard Fund marks 10 years of ‘If You Give a Child a Book …’ campaign with two-day donation match

The E.W. Scripps Company’s philanthropic arm, the Scripps Howard Fund, is marking the 10th anniversary of its 'If You Give a Child a Book …' campaign by doubling donations up to $200,000 over two days to support free book distribution to children in low-income U.S. schools. The initiative aims to foster childhood literacy by providing students with…

RadNet, Inc. to Present at the Jefferies Healthcare Services and Technology Conference on September 15, 2026

RadNet, Inc. to Present at the Jefferies Healthcare Services and Technology Conference on September 15, 2026

RadNet, Inc., a leading US provider of outpatient diagnostic imaging services and related technology solutions, announced that its Executive Vice President and Chief Strategy Officer, Dr. Greg Sorensen, will present at the Jefferies Healthcare Services Conference on September 15, 2026. The presentation will be webcast live and archived for later vi…

AIR Announces Participation in Barclays Global Consumer Conference

AIR Announces Participation in Barclays Global Consumer Conference

AIR Global PLC, a Dubai-headquartered leader in advanced flavored inhalation technologies, announced CEO Stuart Brazier and CFO Bassem Lotfy will participate in a fireside chat at the Barclays Global Consumer Conference. The company highlighted its portfolio of nicotine and social inhalation brands and its focus on innovation and scientific researc…

Beam Therapeutics Presents Updated Clinical Data from the Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the European Respiratory Society (ERS) Congress 2026

Beam Therapeutics Presents Updated Clinical Data from the Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the European Respiratory Society (ERS) Congress 2026

Beam Therapeutics announced updated positive clinical results from its Phase 1/2 trial of BEAM-302, a liver-targeted base editing therapy for Alpha-1 Antitrypsin Deficiency (AATD). Data show that a single dose leads to durable increases in functional alpha-1 antitrypsin protein, reduction of mutant protein, and improved biomarkers associated with l…

Lithia & Driveway (LAD) Continues Strategic Network Expansion in Texas with Rockwall Hyundai Acquisition and Provides Share Repurchase Update

Lithia & Driveway (LAD) Continues Strategic Network Expansion in Texas with Rockwall Hyundai Acquisition and Provides Share Repurchase Update

Lithia & Driveway (NYSE: LAD) has acquired Rockwall Hyundai in Texas, adding approximately $75 million in annualized revenue and strengthening its presence in the Dallas-Fort Worth market. The acquisition increases year-to-date expected annualized revenue acquired to $915 million. Additionally, the company updated its share repurchase program, havi…

Upstream Bio Presents Results from the Phase 2 VALIANT Trial of Verekitug for the Treatment of Severe Asthma in Oral Presentation at ERS Congress 2026

Upstream Bio Presents Results from the Phase 2 VALIANT Trial of Verekitug for the Treatment of Severe Asthma in Oral Presentation at ERS Congress 2026

Upstream Bio announced positive results from the Phase 2 VALIANT trial of verekitug, a novel TSLP receptor antagonist, demonstrating a 56% reduction in annualized asthma exacerbation rate compared to placebo in severe asthma patients. Verekitug also improved lung function and inflammatory biomarkers with favorable safety. The company plans to start…

Unmasking Fraud: Verisk Releases Fraud Discovery, connecting intelligence, analytics and investigations in one powerful fraud platform

Unmasking Fraud: Verisk Releases Fraud Discovery, connecting intelligence, analytics and investigations in one powerful fraud platform

Verisk Analytics has introduced Fraud Discovery, an integrated fraud prevention platform combining intelligence, analytics, network analysis, digital forensics, and case management. The platform aims to help insurers detect and combat increasingly sophisticated and organized fraud schemes by uncovering hidden relationships and prioritizing investig…

Magnite Launches First Agentic Campaign in EMEA With Amnet France

Magnite Launches First Agentic Campaign in EMEA With Amnet France

Magnite (NASDAQ: MGNI) announced the launch of its first agentic campaign in EMEA through collaboration with Amnet France, utilizing AI-powered buyer agents to automate and optimize premium connected TV (CTV) advertising campaigns. The campaign for a leading automotive client resulted in a 70% reduction in setup time and a 95% view-through rate, sh…

ASML and TSMC Announce Initiative to Pioneer Industry Transition to Large-Format Photomasks for High NA EUV

ASML and TSMC Announce Initiative to Pioneer Industry Transition to Large-Format Photomasks for High NA EUV

ASML and TSMC have launched a collaborative industry initiative to transition the semiconductor industry to larger 12-inch photomasks for High Numerical Aperture Extreme Ultraviolet (High NA EUV) lithography. This initiative aims to establish a pilot line by 2031 and enable advanced node production by 2033, improving fab productivity, lowering chip…